Выпуск
Pharmaceutical Executive Daily: Fabrice Chouraqui Steps Down as CEO of Pharming
Pharmaceutical Executive · 29 сентября 2026 г. · 3 мин
New U.S. guidance carves out tariff exemptions for specialty pharmaceuticals, Pharming's Fabrice Chouraqui steps down as CEO amid a board rift, and a dealmaking roundup covers Hengrui Pharma's licensing agreement with Novo Nordisk and AstraZeneca's investment in Summit Therapeutics.